Clinical Trials Browser

INDUSTRY × Carcinoma, Basal Cell × 90 days × Clear all

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03646188 2026-04-16

Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)

Phase 1 Terminated

13 enrolled 12 charts

Dermatologic

Carcinoma, Basal Cell

NCT03737734 2026-04-06

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Phase NA Active not recruiting

30 enrolled

DermatologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Lip Neoplasms, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Tongue Neoplasms

NCT04480645 2026-03-24

CivaDerm(TM) Surface Therapy Pilot Study

Phase EARLY_PHASE1 Completed

10 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT04066504 2026-03-18

NISSO

Completed

323 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07227350 2026-03-10

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Phase 2 Not yet recruiting

180 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT06919809 2026-03-09

Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery

Phase NA Completed

16 enrolled

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

Phase 2 Not yet recruiting

92 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT07428941 2026-02-24

LegitHealth PH

Completed

9 enrolled

Dermatologic

Carcinoma, Basal Cell, Melanoma, Nevus, Pigmented, Skin Diseases, Urticaria, Hidradenitis Suppurativa, Keratosis, Actinic

NCT06422936 2026-01-26

SPOTLIGHT204

Phase 2 Active not recruiting

60 enrolled

Dermatologic

Carcinoma, Basal Cell

Clinical Trials

ARTACUS

Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

CivaDerm(TM) Surface Therapy Pilot Study

NISSO

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery

L19IL2/TNF in Patients With Basal Cell Carcinoma

LegitHealth PH

SPOTLIGHT204